The purpose of this study is to demonstrate that young plasma infusions can be performed
safely in patients with Parkinson's Disease (PD). Secondary outcomes will include behavioral
and laboratory data that will support the next study that will inquire whether young plasma
infusions improve or slow the progression of cognitive, mood and/or motor impairment and rate
markers of the disease.